[CLDX] QoQ Quarter Result on 30-Jun-2013 [#Q2]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
06-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- -9.72%
YoY- -38.07%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Revenue 416 620 980 97 2,414 3,647 3,113 -73.89%
PBT -29,903 -22,062 -23,140 -19,016 -17,332 -16,807 -15,027 58.27%
Tax -1,586 -137 -142 -161 -379 -94 -105 512.06%
NP -29,903 -22,062 -23,140 -19,016 -17,332 -16,807 -15,027 58.27%
Tax Rate - - - - - - - -
Total Cost 30,319 22,682 24,120 19,113 19,746 20,454 18,140 40.88%
Ratio Analysis
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
NP Margin -7,188.22 -3,558.39 -2,361.22 -19,604.12 -717.98 -460.84 -482.72 506.26%
Per Share
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
EPS -5.02 -3.71 -4.28 -3.53 -3.51 -4.03 -3.79 20.62%
EPS Diluted -5.02 -3.71 -4.28 -3.53 -3.51 -4.03 -3.79 20.62%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.